Shopping Cart
- Remove All
- Your shopping cart is currently empty
AT-130 is a HBV virus inhibitor with improved potency (IC50 = 0.13 μM) and reduced toxicity in the HepAD38 cell line. AT-130 blocks HBV replication at the level of viral RNA packaging.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $35 | In Stock | |
5 mg | $83 | In Stock | |
10 mg | $133 | In Stock | |
25 mg | $238 | In Stock | |
50 mg | $356 | In Stock | |
100 mg | $535 | In Stock | |
200 mg | $735 | In Stock | |
1 mL x 10 mM (in DMSO) | $89 | In Stock |
Description | AT-130 is a HBV virus inhibitor with improved potency (IC50 = 0.13 μM) and reduced toxicity in the HepAD38 cell line. AT-130 blocks HBV replication at the level of viral RNA packaging. |
Targets&IC50 | HBV:0.13 μM |
Alias | AT 130 |
Molecular Weight | 488.33 |
Formula | C22H22BrN3O5 |
Cas No. | 211364-06-6 |
Smiles | COc1ccccc1\C(Br)=C(/NC(=O)c1ccc(cc1)[N+]([O-])=O)C(=O)N1CCCCC1 |
Relative Density. | 1.459 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 23 mg/mL (47.09 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.